Reaction

Interleukin Level Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 527 reports · 23 co-occurring drugs

As of the last recalculation, Interleukin Level Increased appears in 527 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 247.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Canakinumab60247.0248.4
Anakinra70192.0192.8
Blinatumomab1350.450.5
Amphotericin B1445.345.4
Leucovorin Calcium2042.943.0
Bendamustine Hcl1539.339.3
Sodium Chloride Tablet5230.930.9
Sodium Chloride Tablets5230.930.9
Cetirizine Hydrochloride Allergy2229.929.9
Cetirizine Hydrochloride Tablets2229.929.9
Fludarabine Phosphate2829.629.7
Sodium Chloride5329.329.4
Axicabtagene Ciloleucel728.428.4
Tocilizumab7128.228.3
Ruxolitinib4325.725.7
Polatuzumab Vedotin624.624.6
Tofacitinib Citrate824.524.5
Oxaliplatin4224.224.2
Fluorouracil Cream, 0.5%3821.121.1
Fluorouracil3820.820.8
Remdesivir618.018.0
Alteplase513.313.3
Durvalumab59.89.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.